These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 464587)

  • 1. Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice.
    Field HJ; Bell SE; Elion GB; Nash AA; Wildy P
    Antimicrob Agents Chemother; 1979 Apr; 15(4):554-61. PubMed ID: 464587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.
    Klein RJ; Friedman-Kien AE; DeStefano E
    Antimicrob Agents Chemother; 1979 May; 15(5):723-9. PubMed ID: 230784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 2 latency in the footpad of mice: effect of acycloguanosine on the recovery of virus.
    Al-Saadi SA; Gross P; Wildy P
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():433-8. PubMed ID: 2828517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Svennerholm B; Vahlne A; Lycke E
    Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral treatment with acyclovir and bromovinyldeoxyuridine on the establishment of maintenance of latent herpes simplex virus infection in mice.
    Field HJ; De Clercq E
    J Gen Virol; 1981 Oct; 56(Pt 2):259-65. PubMed ID: 6273499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acycloguanosine treatment of herpesvirus infections in footpads and nervous tissue of normal and immunosuppressed mice.
    Mayo DR; Richards JC; Rapp F
    Intervirology; 1980; 12(6):345-8. PubMed ID: 6244239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.
    Hill TJ; Field HJ; Blyth WA
    J Gen Virol; 1975 Sep; 28(3):341-53. PubMed ID: 170376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-lethal test of the resistance of inbred mice to herpes simplex virus type 1.
    Collier LH; Scott QJ
    J Hyg (Lond); 1982 Oct; 89(2):335-45. PubMed ID: 6290567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent herpes simplex virus infection of mice. Infectious virus in homogenates of latently infected dorsal root ganglia.
    Schwartz J; Whetsell W; Elizan TS
    J Neuropathol Exp Neurol; 1978 Jan; 37(1):45-55. PubMed ID: 201734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy.
    Field HJ
    Antimicrob Agents Chemother; 1982 May; 21(5):744-52. PubMed ID: 7103454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.
    Field HJ; Darby G
    Antimicrob Agents Chemother; 1980 Feb; 17(2):209-16. PubMed ID: 6247969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation.
    McLennan JL; Darby G
    J Gen Virol; 1980 Dec; 51(Pt 2):233-43. PubMed ID: 6262435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acyclovir on recurrence of herpes simplex skin lesions in mice.
    Blyth WA; Harbour DA; Hill TJ
    J Gen Virol; 1980 Jun; 48(Pt 2):417-9. PubMed ID: 6249889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pyran on latency after herpes simplex virus infections.
    Morahan PS; Cline PF; Breinig MC; Murray BK
    Antimicrob Agents Chemother; 1979 Apr; 15(4):547-53. PubMed ID: 464586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic efficacy of E-5-(2-bromovinyl)-2'deoxyuridine for orofacial infection with herpes simplex virus type 1 in mice.
    Park NH; Pavan-Langston D; Boisjoly HM; De Clercq E
    J Infect Dis; 1982 Jun; 145(6):909-13. PubMed ID: 6979592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    Klein RJ
    Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent stability of herpes simplex virus genomes isolated from primary and recurrent infections and dorsal root ganglia in the mouse.
    Blondeau JM; Embil JA; McFarlane ES
    J Med Microbiol; 1988 Dec; 27(4):291-6. PubMed ID: 2848947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus latent infection: reactivation and elimination of latency after neurectomy.
    Tenser RB; Edris WA; Hay KA
    Virology; 1988 Nov; 167(1):302-5. PubMed ID: 2847420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus infection in populations of mouse dorsal root ganglion neurons: effects of inoculation route and virus strain.
    Henken DB; Martin JR
    J Neurol Sci; 1991 Sep; 105(1):29-36. PubMed ID: 1665505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.